Transcriptomics

Dataset Information

0

D-Serine activates glycolysis via mTOR pathway in kidney remodeling and suppresses onset of diabetes


ABSTRACT: D-Serine, a long-term undetected enantiomer of serine1,2, is a novel biomarker that reflects kidney function and disease activity3-5 and has unclear physiological functions. Here we show that D-serine is a physiological molecule that promotes tissue remodeling and suppresses the onset of diabetes. D-serine is quickly and dominantly distributed to the kidney upon injection in mice, suggesting that the kidney is a key target organ. Unilateral nephrectomy in human living kidney donors decreases urinary excretion and thus increases the blood level of D-serine, which in turn promotes the compensatory enlargement of the remnant kidney in mouse model. D-Serine activates cell cycle for tissue remodeling through an mTOR-related pathway, which promotes metabolic reprograming to glycolytic activation. In rodent diabetic model, D-serine promotes glycolysis in the kidney and suppresses the surge of blood glucose levels. D-Serine has physiological activity that influences kidney function and maintains metabolic homeostasis to reduce diabetic propensity.

ORGANISM(S): Mus musculus

PROVIDER: GSE155475 | GEO | 2022/04/07

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA649903 | ENA
2024-07-23 | GSE272375 | GEO
2017-03-01 | GSE84512 | GEO
2022-03-01 | GSE194367 | GEO
2017-06-17 | GSE70012 | GEO
2022-05-27 | GSE178319 | GEO
2022-03-23 | GSE188966 | GEO
2020-01-20 | PXD012210 | Pride
2024-05-24 | GSE267813 | GEO
| PRJNA129569 | ENA